Head and neck squamous cell carcinoma (HNSCC)—expressing high-integrin β1 was correlated with metastatic potential, a low survival in patients by modulating metalloproteinase-2 (MMP-2) activation (37). The gene discussed is MMP2; the disease is head and neck squamous cell carcinoma.